GM ALL-LOTTOS-HHII .0015-NEWS-AGAIN HHII Developing

New Post Public Reply Private Reply Replies (0) Message Board
FLA

GM ALL-LOTTOS-[b]HHII [/b].0015-NEWS-AGAIN



HHII Developing All Natural Home Cleaning Products Safe for Patients       08/10 08:00 AM



VERO BEACH, FL -- (MARKETWIRE) -- 08/10/12 -- Home Health International Inc. (HHII:$0.0015,$0.00,000.00%) , a Medicare-certified home health agency and durable medical equipment (DME) supplier, announced today that the Company is currently developing a line of natural home cleaning products.
Home Health International (HHII:$0.0015,$0.00,000.00%) is developing a line of natural home cleaning products that will be safe to use around people with certain medical conditions that cause them to be hypersensitive to harsh chemicals and irritants. Many household and commercial cleaning supplies can irritate the eyes or throat, cause headaches, or complicate other health problems. Volatile organic compounds (VOCs) and chemicals released when using cleaning supplies can exacerbate respiratory illnesses, asthma and allergies.
To start, Home Health (HHII:$0.0015,$0.00,000.00%) plans to introduce three products to the market: laundry soap, surface cleaner, and floor cleaner. These products will be free of dyes, harsh chemicals, and heavy fragrances. Home Health International (HHII:$0.0015,$0.00,000.00%) intends to sell its line of natural home cleaning products on the Company's online DME store. Additionally, these hypo-allergenic products will be used by Home Health (HHII:$0.0015,$0.00,000.00%) agency staff to clean patients' homes.
The natural home cleaning product line will serve as an additional revenue stream for Home Health International (HHII:$0.0015,$0.00,000.00%) . The Company's business plan calls for incorporating its DME products into its home health care agency services wherever possible to maximize revenue growth, and the introduction of a home cleaning products line fully adheres to that principle. The Company plans to grow the product line over time, eventually adding products such as window cleaner, bathroom cleaner, and all-purpose cleaner.
For more information about Home Health International Inc. (HHII:$0.0015,$0.00,000.00%) , visit the corporate website at www.homehealthintl.com.
About Home Health International Inc. (HHII:$0.0015,$0.00,000.00%)
Home Health International Inc. (HHII:$0.0015,$0.00,000.00%) was incorporated in the State of Nevada on September 13, 2006. The Company was formerly known as Micro Mammoth Solutions, Inc. and operated as such until January 25, 2010. On January 26, 2010, the Board of Directors of the Company approved a Stock Purchase Agreement between the Company and all of the shareholders of Atlas Capital Partners, LLC. Following the acquisition of Atlas Capital Partners the shareholders approved an amendment to the Company's Articles of Incorporation changing the Company's name from Micro Mammoth Solutions, Inc. to Atlas Capital Holdings, Inc. The Company received shareholder and board approval to amend its Articles of Incorporation to change its name to Home Health International Inc. (HHII:$0.0015,$0.00,000.00%) This change was approved by FINRA and became effective on March 26, 2012.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Home Health International Inc. (HHII:$0.0015,$0.00,000.00%) undertakes no obligation to update such statements.
CONTACT:
Home Health International Inc. (HHII:$0.0015,$0.00,000.00%)
info@homehealthintl.com


Get more news on:SYMBOLS: HHIINEWS TYPE: SECTORS: Materials, Chemicals

I ONLY POST WHAT I PLAY
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Infosys Pushes AI Growth with Strong Deal Wins

Updated Category News Views 17

Riding the AI Wave Who knew Infosys was a lightning rod for AI momentum, eh? With a 29% quarterly surge in AI revenue, the firm's really putting AI strategy at center stage. Considering today's finicky markets, that's not just peanuts. CEO Salil Parekh's swagger is backed by real numbers, seeing AI revenue inch to 10.5% of total haul. This ain't just talk—Infosys is...

Continue Reading
PZZA Faces Class Action: Strategic Shake-up or Misstep?

Updated Category News Views 10

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

Continue Reading
FDA Nod for Subcutaneous SKYRIZI in Crohn's Disease

Updated Category News Views 48

AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...

Continue Reading
Honeywell Aerospace Faces Class Action: Deadline Looms

Updated Category News Views 37

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....

Continue Reading
SLM Faces Legal Scrutiny as Losses Mount Amid Pause

Updated Category News Views 36

SLM's Latest Troubles: Legal and Financial Impact Ah, student loans—not just a headache for borrowers but now for lenders too. SLM Corporation, that name we know all too well in the student debt circus, has hit a snag. They've paused most of their third-party recovery activities. Let's dig in: net charge-offs for SLM in the third quarter shot up to a hefty $90.4...

Continue Reading
Pathalys' Phase 3 Data Shows Promise for CKD Drug

Updated Category News Views 30

A Glimpse at Pathalys Pharma's Recent Win This is some groundbreaking stuff emerging from Pathalys Pharma. Their investigational drug, upacicalcet, has just clinched a significant victory in two crucial Phase 3 trials - PATH-1 and PATH-2 - aimed at treating Secondary Hyperparathyroidism (SHPT) in patients with end-stage kidney disease undergoing hemodialysis. With SHPT...

Continue Reading
Stephen A. Smith Calls for Corporate Support of HBCUs

Updated Category News Views 4

A Stand for Education at the White House Stephen A. Smith stirred the pot with his decision to attend a White House dinner, a move that had tongues wagging across the media landscape. But this time, it wasn't about the usual hustle and bustle of the sports world. Smith had his sights set on the big picture, specifically, the long-term financial stability of Historically...

Continue Reading
Violet PR's Big Wins Hint at Industry Strategies

Updated Category News Views 15

A Shining Night in Morristown Picture Violet PR's team on top of the world, right there in Morristown, getting the accolades every agency dreams of—five awards from PRSA-NJ. It's not just an ego trip, either. This is about setting a high bar in the world of strategic communications, and they're flaunting their ability to drive growth and innovation in the economic...

Continue Reading
BOB Raises $5.5M for AI Banking Platform Revolution

Updated Category News Views 24

Cracking the Code of Small Business Finance BOB, a Miami hotshot aiming to be more than just another fintech flash in the pan, has wrangled a sweet $5.5 million in seed capital. They're shaking hands with big names like Peter Thiel and the mastermind behind Plaid, Zak Perret, through Mischief Ventures. The plan? To build an AI-powered finance savior for small businesses...

Continue Reading
GeeLark's Tech Leap: Expanding Cloud Phone Functions

Updated Category News Views 3

GeeLark's New Frontier GeeLark is kicking up some dust in the tech space by tooling up its cloud phone workflows with an arsenal of new supports: API, CLI, and MCP. This isn't just some minor patch, folks. It's a bold move, and for those in the quicksand of digital operations, a game-changer. You know how much of a drag it is repeating the same setup steps over and over?...

Continue Reading

Top 5 Most Recently Viewed Articles

CoinW Showcases Its Innovations at Taipei Blockchain Week 2024

Updated Category News Views 261

CoinW's Impactful Presence at Taipei Blockchain Week 2024 At the forefront of innovation and security, CoinW, a globally recognized cryptocurrency exchange, recently showcased its vision for the future during Taipei Blockchain Week 2024 as a Gold Sponsor. The event, celebrated for fostering discussions on blockchain advancements, featured the launch of PropW, CoinW's...

Continue Reading
Bank of Åland Plc Seeks Trading Admission of New Covered Bonds

Updated Category News Views 170

Application for Trading Admission of Covered Bonds Bank of Åland Plc, also recognized as Ålandsbanken Abp, is taking an important step by applying for the admission of a new security to trading on Nasdaq Helsinki. This involves their recent issuance of covered bonds, which are highly regarded in the financial market. Details of the Covered Bonds Issue The primary...

Continue Reading
Simpson Manufacturing's Q3 Earnings Report Shows Challenges Ahead

Updated Category News Views 54

Simpson Manufacturing's Third Quarter Performance Simpson Manufacturing Co., Inc. (NYSE: SSD) recently announced its third-quarter earnings, and the results did not meet the expectations of analysts. This disappointing performance resulted in a 5% decline in shares during after-hours trading. The company's focus on producing wood construction products highlights the...

Continue Reading
Alvotech Faces Challenges in Biologics License Approval Process

Updated Category News Views 349

Overview of Biologics License Application Status Alvotech, a prominent biotech firm specializing in biosimilars, has recently updated the market regarding its application status for AVT05, a potential competitor to Simponi (golimumab). The company has received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) highlighting certain...

Continue Reading
Replimune Group Faces Class Action Lawsuit Amid FDA Setback

Updated Category News Views 127

Replimune Group Faces Class Action Lawsuit Amid FDA Setback Pomerantz LLP has brought attention to a class action lawsuit involving Replimune Group, Inc. (NASDAQ: REPL). This legal action is relevant for investors who have experienced losses on their investments in the company. It's crucial for affected investors to be proactive and consider their options as they navigate...

Continue Reading